Buffl

3. Special Topics I Mergers and Acquisitions

LK
von Linus K.

What are types of mergers? How can an acquirer pay?

While we tend to talk about merger waves and mergers in general, the term “merger,” as commonly used, encompasses several types of transactions that vary by the relation between the target and the acquirer and by the method of payment used in the transaction.

If the target and acquirer are in the same industry, the merger is typically called a horizontal merger,

whereas if the target’s industry buys or sells to the acquirer’s industry, it is called a vertical merger.

Finally, if the target and acquirer operate in unrelated industries, the deal is a conglomerate merger. Conglomerate mergers, while popular in the 1960s, have generally fallen out of favour with shareholders because of the difficulty in creating value when combining two unrelated businesses.

Deals also vary based on whether the target shareholders receive stock or cash as payment for target shares. When they receive stock, the deal is often called a stock swap, because target shareholders are swapping their old stock for new stock in either the acquirer or the newly created merged firm. The consideration paid to target shareholders can be very complex, including debt instruments, options, and mixes of any of these with cash and/ or stock. Commonly, however, target shareholders receive stock, cash, or a mix of the two.

While news reports understandably focus on the price and method of payment, the structure of a merger transaction, summarized in a term sheet, can be simple or incredibly complex. The items to negotiate include, among other things, who will run the new company, the size and composition of the new board, the location of the headquarters, and even the name of the new company.

Reasons to acquire: Diversification

The benefits of diversification are frequently cited as a reason for a conglomerate merger. The justification for these benefits comes in three forms: direct risk reduction, lower cost of debt or increased debt capacity, and liquidity enhancement. We discuss each in turn.

Risk Reduction. Like a large portfolio, large firms bear less idiosyncratic risk, so often mergers are justified on the basis that the combined firm is less risky. The problem with this argument is that it ignores the fact that investors can achieve the benefits of diversification themselves by purchasing shares in the two separate firms. Because most stockholders will already be holding a well-diversified portfolio, they get no further benefit from the firm diversifying through acquisition. Moreover, as we have already pointed out, there are costs associated with merging and with running a large diversified firm. Because it may be harder to measure performance accurately in a conglomerate, agency costs may increase and re- sources may be inefficiently allocated across divisions.6 As a result, it is cheaper for inves- tors to diversify their own portfolios than to have the corporation do it through acquisition.

Debt Capacity and Borrowing Costs. All else being equal, larger, more diversified firms have a lower probability of bankruptcy given the same degree of leverage. Consequently, such firms can increase leverage further and enjoy greater tax savings without incurring significant costs of financial distress. Thus, increased tax benefits and reduction in bankruptcy costs from leverage are potential benefits of diversifying mergers. Of course, to justify a merger, these gains must be large enough to offset any disadvantages of running a larger, less-focused firm.

Asset Allocation. A diversified conglomerate may benefit by being able to quickly reallocate assets across industries. For example, the firm may redeploy managerial talent to where it is most needed to exploit emerging opportunities. It may also reallocate capital from less productive divisions to those with a higher return on investment, without having to engage in costly external fundraising. On the other hand, agency costs may lead to the opposite result: profitable divisions may subsidize money-losing ones for longer than is optimal.

Liquidity. Shareholders of private companies are often under-diversified: They have a disproportionate share of their wealth invested in the private company. Consequently, when an acquirer buys a private target, it provides the target’s owners with a way to reduce their risk exposure by cashing out their investment in the private target and reinvesting in a diversified portfolio. This liquidity that the bidder provides to the owners of a private firm can be valuable and often is an important incentive for the target shareholders to agree to the takeover.

What are possible Tax and Accounting Issues?

Any cash received in full or partial exchange for shares triggers an immediate tax liability for target shareholders. They will have to pay a capital gains tax on the difference between the price paid for their shares in the takeover and the price they paid when they first bought the shares. If the acquirer pays for the take-over entirely by exchanging bidder stock for target stock, then the tax liability is deferred until the target shareholders actually sell their new shares of bidder stock.

If the acquirer purchases the target assets directly (rather than the target stock), then it can step up the book value of the target’s assets to the purchase price. This higher depreciable basis reduces future taxes through larger depreciation charges. Further, any goodwill created could also be amortized for tax purposes over 15 years. The same treatment applies to a forward cash-out merger, where the target is merged into the acquirer and target share-holders receive cash in exchange for their shares.

While the method of payment (cash or stock) affects how the value of the target’s assets is recorded for tax purposes, it does not affect the combined firm’s financial statements for financial reporting. The combined firm must mark up the value assigned to the target’s assets on the financial statements by allocating the purchase price to target assets according to their fair market value. If the purchase price exceeds the fair market value of the target’s identifiable assets, then the remainder is recorded as goodwill and is examined annually by the firm’s accountants to determine whether its value has decreased

What is a friendly- and a hostile takeover?

For a merger to proceed, both the target and the acquiring board of directors must approve the deal and put the question to a vote of the shareholders of the target (and, in some cases, the shareholders of the acquiring firm as well).

In a friendly takeover, the target board of directors supports the merger, negotiates with potential acquirers, and agrees on a price that is ultimately put to a shareholder vote. Although it is rare for acquiring boards to oppose a merger, target boards sometimes do not support the deal even when the acquirer offers a large premium. In a hostile takeover, the board of directors (together with upper-level management) fights the takeover attempt. To succeed, the acquirer must garner enough shares to take control of the target and replace the board of directors. When a takeover is hostile, the acquirer is often called a raider.

If the shareholders of a target company receive a premium over the current market value of their shares, why would a board of directors ever oppose a takeover? There are a number of reasons. The board might legitimately believe that the offer price is too low. In this case, a suitor that is willing to pay more might be found or the original bidder might be convinced to raise its offer. Alternatively, if the offer is a stock-swap, target management

may oppose the offer because they feel the acquirer’s shares are over-valued, and therefore that the value of the offer is actually less than the stand-alone value of the target. Finally, managers (and the board) might oppose a takeover because of their own self-interests, especially if the primary motivation for the takeover is efficiency gains. In this case, the ac- quirer most likely plans to undertake a complete change of leadership of the corporation. Upper-level managers could view opposing the merger as a way of protecting their jobs (and the jobs of their employees). In fact, this concern is perhaps the single biggest reason for the negative associations that hostile takeovers generate. Bear in mind that if substantial efficiency gains are indeed possible, current management is not doing an effective job. A takeover, or threat thereof, might be the only recourse investors have to fix the problem.

In theory, the duty of the target board of directors is to choose the course of action that is in the best interests of the target shareholders. In practice, the courts have given target directors wide latitude under what is called the “business judgment rule” to determine the best course for their companies, including spurning a premium offer if the directors can rea- sonably argue that more value will eventually be realized for their shareholders by remaining independent. The premise of this rule is that absent evidence of misconduct or self-dealing, the court will not substitute its judgment for that of the elected, informed directors.

Takeover defenses: Poison Pills

A poison pill is a rights offering that gives existing target shareholders the right to buy shares in the target at a deeply discounted price once certain conditions are met. The acquirer is specifically excluded from this right. Because target shareholders can purchase shares at less than the market price, the rights offering dilutes the value of any shares held by the acquirer. This dilution makes the takeover so expensive for the acquiring shareholders that they choose to pass on the deal.

Because the original poison pill goes into effect only in the event of a complete takeover (that is, a purchase of 100% of the outstanding shares), one way to circumvent it is to not do a complete takeover. by adopting a poison pill, a company effectively entrenches its management by making it much more difficult for shareholders to replace bad managers, thereby po- tentially destroying value. Financial research has verified this effect. A firm’s stock price typically drops when it adopts a poison pill. Furthermore, once adopted, firms with poison pills have below-average financial performance.16

Not surprisingly, companies adopting poison pills are harder to take over, and when a takeover occurs, the premium that existing shareholders receive for their stock is higher. Therefore, because a poison pill increases the cost of a takeover, all else being equal, a target company must be in worse shape (there must be a greater opportunity for profit) to justify the expense of waging a takeover battle.

Poison pills also increase the bargaining power of the target firm when negotiating with the acquirer because they make it difficult to complete the takeover without the coopera- tion of the target board. If used effectively, this bargaining power can allow target share- holders to capture more of the takeover gains by negotiating a higher premium than they would get if no pill existed. Numerous studies on the impact of anti-takeover provisions on takeovers have found that such provisions result in higher premiums accruing to exist- ing shareholders of the target company.17


Author

Linus K.

Informationen

Zuletzt geändert